Axa’s Nature's Sunshine NATR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-19,205
| Closed | -$383K | – | 1282 |
|
|
2021
Q1 | $383K | Hold |
19,205
| – | – | ﹤0.01% | 1106 |
|
|
2020
Q4 | $287K | Sell |
19,205
-2,700
| -12% | -$33.4K | ﹤0.01% | 1139 |
|
|
2020
Q3 | $253K | Hold |
21,905
| – | – | ﹤0.01% | 1127 |
|
|
2020
Q2 | $197K | Sell |
21,905
-6,413
| -23% | -$55.7K | ﹤0.01% | 1181 |
|
|
2020
Q1 | $230K | Sell |
28,318
-1,650
| -6% | -$15K | ﹤0.01% | 1087 |
|
|
2019
Q4 | $268K | Hold |
29,968
| – | – | ﹤0.01% | 1093 |
|
|
2019
Q3 | $248K | Hold |
29,968
| – | – | ﹤0.01% | 1220 |
|
|
2019
Q2 | $278K | Sell |
29,968
-7,235
| -19% | -$67.7K | ﹤0.01% | 1180 |
|
|
2019
Q1 | $346K | Buy |
37,203
+19,565
| +111% | +$166K | ﹤0.01% | 1162 |
|
|
2018
Q4 | $144K | Hold |
17,638
| – | – | ﹤0.01% | 1259 |
|
|
2018
Q3 | $154K | Hold |
17,638
| – | – | ﹤0.01% | 1306 |
|
|
2018
Q2 | $165K | Hold |
17,638
| – | – | ﹤0.01% | 1314 |
|
|
2018
Q1 | $194K | Hold |
17,638
| – | – | ﹤0.01% | 1327 |
|
|
2017
Q4 | $204K | Hold |
17,638
| – | – | ﹤0.01% | 1308 |
|
|
2017
Q3 | $179K | Buy |
17,638
+5,534
| +46% | +$62.7K | ﹤0.01% | 1277 |
|
|
2017
Q2 | $160K | Hold |
12,104
| – | – | ﹤0.01% | 1215 |
|
|
2017
Q1 | $121K | Buy |
12,104
+1,701
| +16% | +$19.8K | ﹤0.01% | 1246 |
|
|
2016
Q4 | $156K | Sell |
10,403
-11,890
| -53% | -$173K | ﹤0.01% | 1218 |
|
|
2016
Q3 | $357K | Sell |
22,293
-30,888
| -58% | -$403K | ﹤0.01% | 1070 |
|
|
2016
Q2 | $507K | Hold |
53,181
| – | – | ﹤0.01% | 1005 |
|
|
2016
Q1 | $511K | Buy |
53,181
+4,054
| +8% | +$35K | ﹤0.01% | 994 |
|
|
2015
Q4 | $497K | Sell |
49,127
-1,727
| -3% | -$20.1K | ﹤0.01% | 1032 |
|
|
2015
Q3 | $609K | Buy |
50,854
+1,602
| +3% | +$19.9K | ﹤0.01% | 1013 |
|
|
2015
Q2 | $677K | Buy |
49,252
+800
| +2% | +$10.3K | ﹤0.01% | 1022 |
|
|
2015
Q1 | $636K | Sell |
48,452
-2,600
| -5% | -$35.5K | ﹤0.01% | 1040 |
|
|
2014
Q4 | $757K | Buy |
51,052
+10,152
| +25% | +$150K | ﹤0.01% | 1031 |
|
|
2014
Q3 | $606K | Buy |
40,900
+1,600
| +4% | +$25.3K | ﹤0.01% | 1015 |
|
|
2014
Q2 | $667K | Buy |
39,300
+823
| +2% | +$11.8K | ﹤0.01% | 1015 |
|
|
2014
Q1 | $530K | Buy |
38,477
+12,582
| +49% | +$199K | ﹤0.01% | 1053 |
|
|
2013
Q4 | $449K | Buy |
25,895
+11,072
| +75% | +$204K | ﹤0.01% | 1086 |
|
|
2013
Q3 | $283K | Buy |
14,823
+823
| +6% | +$15.2K | ﹤0.01% | 1100 |
|
|
2013
Q2 | $229K | Buy |
+14,000
| New | +$216K | ﹤0.01% | 1094 |
|
Other funds holding NATR
FI
WC
PCMI
PGCM
KCM
Axa's NATR Position: Q2 2021 in Review
Axa sold out of Nature's Sunshine (NATR) in Q2 2021, closing a stake of 19,205 shares — an estimated $383K sold.
Axa first reported a position in NATR in Q2 2013 and held it in 32 quarters. The position peaked at $757K in Q4 2014. 77 funds tracked by Wall St. Rank hold NATR as of Q2 2021.
- Axa reported no remaining Nature's Sunshine position as of Q2 2021 after selling out during the quarter.
- Axa sold 19,205 Nature's Sunshine shares in Q2 2021, an estimated $383K.
- Axa first reported a position in Nature's Sunshine in Q2 2013 and held it in 32 quarters.
- Axa's Nature's Sunshine position peaked at $757K in Q4 2014.
- 77 funds tracked by Wall St. Rank held Nature's Sunshine as of Q2 2021.
Based on Axa's 13F filing for Q2 2021, filed 13 Aug 2021.